Mylan Sues Procter & Gamble and Watson Over "Authorized Generic"

Law360, New York (March 24, 2004, 12:00 AM EST) -- Mylan Laboratories has filed a lawsuit against Procter & Gamble and Watson Pharmaceuticals, alleging that Watson’s “authorized generic” deal for Procter & Gamble's Macrobid antibiotic (nitrofurantoin) during Mylan's 180-day exclusivity period violates the law.

The lawsuit claims that the agreement between the two companies undermines Hatch-Waxman legislation, which provides an incentive and various rights to a company that successfully challenges patents, according to Mylan.

The lawsuit seeks declaratory and injunctive relief and restitution to consumers and third party payors.

Watson started shipping the drug on Wednesday...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.